Literature DB >> 28274689

Combined Wharton's jelly derived mesenchymal stem cells and nerve guidance conduit: A potential promising therapy for peripheral nerve injuries.

Sally M Shalaby1, Amal S El-Shal2, Faiza E Ahmed3, Sahar F Shaban3, Rania A Wahdan3, Wael A Kandel4, Mohammed S Senger4.   

Abstract

BACKGROUND: Peripheral nerve injuries represent a clinical problem with insufficient or unsatisfactory treatment options. Functional outcome with nerve guidance conduits was unsatisfactory in nerve defects with increased gap size. So, cell therapy may benefit as a tool for optimizing the regeneration process. The aim of the present study was to evaluate the impact of combination of cell therapy and nerve guidance conduits on the nerve regeneration and on the expression of the factors aiding the regeneration in a rat model of sciatic nerve injury. METHODS AND
RESULTS: Sixty Wistar rats were randomly divided into four groups: Group I: normal control group; Group II: sciatic nerve injury (SNI) with a 10mm long sciatic nerve gap; Group III: SNI with using a nerve conduit (NC) for nerve gap bridging; and Group IV: SNI with using a NC associated with Wharton's jelly derived mesenchymal stem cells (WJ-MSCs). The results showed that the combination therapy NC+WJ-MSCs caused much better beneficial effects than NC alone evidenced by increasing sciatic nerve index and pin-prick score. The histopathological analysis found that the use of the NC combined with WJ[HYPHEN]MSCs resulted in a structure of the sciatic nerve comparable to the normal one with better nerve regeneration when compared with NC only. There was no differentiation of WJ-MSCs into nerve structure. Lastly, there was an upregulation of expression for netrin-1, ninjurin, BDNF, GDNF, VEGF and angiopoitin-1 rat genes in NC+WJ-MSCs group than NC alone.
CONCLUSION: The addition of WJ-MSCs to the nerve guidance conduits seems to bring significant advantage for nerve regeneration, basically by increasing the expression of neurotrophic and angiogenic factors establishing more favorable environment for nerve regeneration.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenic factors; Mesenchymal stem cells; Nerve conduit; Nerve regeneration; Neurotrophic factors; Peripheral nerve; WJ-MSCs

Mesh:

Substances:

Year:  2017        PMID: 28274689     DOI: 10.1016/j.biocel.2017.03.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  3 in total

Review 1.  Endometrium Derived Stem Cells as Potential Candidates in Nervous System Repair.

Authors:  Yifen Yan; Xiaoli Wang; Guijuan Zhu
Journal:  Ann Biomed Eng       Date:  2022-03-02       Impact factor: 3.934

2.  Topical Application of Human Wharton's Jelly Mesenchymal Stem Cells Accelerates Mouse Sciatic Nerve Recovery and is Associated with Upregulated Neurotrophic Factor Expression.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh; Hsin-Hsin Shen; Sing-Ying Hsieh; Ing-Kae Wang; Sheng-Hao Chuang; Fu-Chan Wei
Journal:  Cell Transplant       Date:  2019-09-30       Impact factor: 4.064

3.  Mesenchymal Stem Cell Treatment Perspectives in Peripheral Nerve Regeneration: Systematic Review.

Authors:  Andrea Lavorato; Stefania Raimondo; Marina Boido; Luisa Muratori; Giorgia Durante; Fabio Cofano; Francesca Vincitorio; Salvatore Petrone; Paolo Titolo; Fulvio Tartara; Alessandro Vercelli; Diego Garbossa
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.